← Back to Search

Mindfulness Training for Autism

N/A
Waitlist Available
Led By Brittany B Braden, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 89 years old, with a special focus on adults with ASD who are going to college given the additional stress of this phase in life. We are recruiting participants across a broad age range in order to maximize our ability to inform interventions for adults with ASD. The upper age limit of 89 years was selected so a de-identified dataset can be created with all participant ages included.
English speaking: Participants must be English-speaking because the screening and behavioral measures are in English (including the intelligence estimate).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (~10 weeks)
Awards & highlights

Study Summary

This trial is studying how well two different stress-reduction classes help adults with ASD manage symptoms by looking at changes in brain functioning.

Who is the study for?
This trial is for English-speaking adults aged 18-89 with Autism Spectrum Disorder (ASD), especially those in college. Participants must be able to attend most of the weekly classes and have an ASD diagnosis confirmed by standard assessments. Excluded are individuals with IQ <70, major medical conditions, seizure history, head trauma, claustrophobia or metal implants that affect MRI safety, and pregnant women.Check my eligibility
What is being tested?
The study compares two stress-reduction techniques over 8 weeks: Mindfulness Based Stress Reduction (MBSR) involving mindfulness strategies and gentle stretching versus a relaxation group offering social support. Brain function before and after these classes will be measured using MRI, EEG, and self-report data to see how brain changes relate to symptom improvement.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions like mindfulness training and relaxation techniques rather than medication or surgery, significant side effects are not anticipated. However, participants may experience discomfort during MRI scans or emotional distress related to discussing personal experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 89 years old, possibly facing college stress.
Select...
I speak English and can understand English materials.
Select...
I can attend at least 7 out of 8 weekly classes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (~10 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (~10 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Beck Depression Inventory - 2
Beck Depression Inventory - II
State-Trait Anxiety Inventory
Secondary outcome measures
World Health Organization Quality of Life
Other outcome measures
Blood-oxygen-level dependent (BOLD) response in brain regions activated during a self-reflection fMRI task
Blood-oxygen-level dependent (BOLD) response in regions activated during an emotion-regulation fMRI task
Event-Related Potentials (ERP) measured during regulation of affective responses

Trial Design

2Treatment groups
Active Control
Group I: Mindfulness Based Stress Reduction ProgramActive Control1 Intervention
Group II: Relaxation GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Banner Alzheimer's InstituteOTHER
7 Previous Clinical Trials
2,612 Total Patients Enrolled
Arizona State UniversityLead Sponsor
278 Previous Clinical Trials
107,029 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
625 Patients Enrolled for Autism Spectrum Disorder
Southwest Autism Research and Resource Center (SARRC)UNKNOWN
1 Previous Clinical Trials
12,000 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
12,000 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being accepted for the current iteration of this clinical trial?

"The data available on clinicaltrials.gov confirms that this particular trial, which was first posted in May 6th 2019 and last updated November 18th 2022 is not presently recruiting patients. Despite this, 271 other trials are currently enrolling participants at the time of writing."

Answered by AI
~19 spots leftby Mar 2025